Literature DB >> 34210848

Data Needs for Economic Evaluations of Screening in Pediatric Primary Care: A Research Framework.

Scott D Grosse1, Alex R Kemper2, Lisa A Prosser3,4.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34210848      PMCID： PMC8312553          DOI： 10.1542/peds.2021-050693J

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   9.703


× No keyword cloud information.
  35 in total

1.  QALYs in 2018-Advantages and Concerns.

Authors:  Peter J Neumann; Joshua T Cohen
Journal:  JAMA       Date:  2018-06-26       Impact factor: 56.272

Review 2.  Using cost-effectiveness analysis to prioritize policy and programmatic approaches to physical activity promotion and obesity prevention in childhood.

Authors:  Angie L Cradock; Jessica L Barrett; Erica L Kenney; Catherine M Giles; Zachary J Ward; Michael W Long; Stephen C Resch; Andrea A Pipito; Emily R Wei; Steven L Gortmaker
Journal:  Prev Med       Date:  2016-10-20       Impact factor: 4.018

3.  Updated Priorities Among Effective Clinical Preventive Services.

Authors:  Michael V Maciosek; Amy B LaFrance; Steven P Dehmer; Dana A McGree; Thomas J Flottemesch; Zack Xu; Leif I Solberg
Journal:  Ann Fam Med       Date:  2017-01-06       Impact factor: 5.166

4.  Economic evaluation of folic acid food fortification in The Netherlands.

Authors:  Janneke Jentink; Nienke W van de Vrie-Hoekstra; Lolkje T W de Jong-van den Berg; Maarten J Postma
Journal:  Eur J Public Health       Date:  2008-01-31       Impact factor: 3.367

5.  A cost-effectiveness analysis of folic acid fortification policy in the United States.

Authors:  Tanya Gk Bentley; Milton C Weinstein; Walter C Willett; Karen M Kuntz
Journal:  Public Health Nutr       Date:  2008-07-01       Impact factor: 4.022

6.  Cost-effectiveness of preventive oral health care in medical offices for young Medicaid enrollees.

Authors:  Sally C Stearns; R Gary Rozier; Ashley M Kranz; Bhavna T Pahel; Rocio B Quiñonez
Journal:  Arch Pediatr Adolesc Med       Date:  2012-10

7.  Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.

Authors:  Kirsten Bibbins-Domingo; David C Grossman; Susan J Curry; Karina W Davidson; John W Epling; Francisco A R García; Matthew W Gillman; Alex R Kemper; Alex H Krist; Ann E Kurth; C Seth Landefeld; Michael LeFevre; Carol M Mangione; Douglas K Owens; William R Phillips; Maureen G Phipps; Michael P Pignone; Albert L Siu
Journal:  JAMA       Date:  2016-08-09       Impact factor: 56.272

8.  Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.

Authors:  Gillian D Sanders; Peter J Neumann; Anirban Basu; Dan W Brock; David Feeny; Murray Krahn; Karen M Kuntz; David O Meltzer; Douglas K Owens; Lisa A Prosser; Joshua A Salomon; Mark J Sculpher; Thomas A Trikalinos; Louise B Russell; Joanna E Siegel; Theodore G Ganiats
Journal:  JAMA       Date:  2016-09-13       Impact factor: 56.272

9.  Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis.

Authors:  Scott D Grosse
Journal:  Healthcare (Basel)       Date:  2015-11-11

Review 10.  Discounting in Economic Evaluations.

Authors:  Arthur E Attema; Werner B F Brouwer; Karl Claxton
Journal:  Pharmacoeconomics       Date:  2018-07       Impact factor: 4.981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.